Literature DB >> 33150435

Blood culture positivity rate for Trypanosoma cruzi in patients with chronic Chagas disease differs among different clinical forms.

Marco Antonio Prates Nielebock1, Luciana de Freitas Campos Miranda1, Pedro Emmanuel Alvarenga Americano do Brasil1, Thayanne Oliveira de Jesus S Pereira1, Aline Fagundes da Silva1, Alejandro Marcel Hasslocher-Moreno1, Luiz Henrique Conde Sangenis1, Roberto Magalhães Saraiva1.   

Abstract

BACKGROUND: The purpose of this research was to compare the clinical and epidemiological characteristics of patients with chronic Chagas disease with and without positive blood cultures for Trypanosoma cruzi.
METHODS: This was a retrospective longitudinal study that included 139 patients with chronic Chagas disease who underwent blood culture for T. cruzi. Blood cultures were performed using Novy-MacNeal-Nicolle medium enriched with Schneider's medium. Multivariate Cox proportional hazards regression analysis adjusting for age and sex was performed to identify if positive blood culture for T. cruzi was associated with all-cause mortality.
RESULTS: The blood culture positivity rate was 30.9%. Most patients were born in the Northeast and Southeast regions of Brazil. Patients with positive blood cultures were older (52±13 vs 45±13 y; p=0.0009) and more frequently women (72.1% vs. 53.1%; p=0.03) than patients with negative blood cultures. The frequency of patients with cardiac or cardiodigestive forms was higher among patients with positive vs negative blood cultures (74.4% vs 54.1%; p=0.02). A total of 28 patients died during a mean follow-up time of 6.6±4.1 y. A positive blood culture was associated with all-cause mortality (hazard ratio 2.26 [95% confidence interval 1.02 to 5.01], p=0.045).
CONCLUSIONS: We found a higher proportion of patients with Chagas heart disease among patients with T. cruzi-positive blood cultures. A positive blood culture was associated with an increased risk of all-cause mortality. Therefore T. cruzi persistence may influence Chagas disease pathogenesis and prognosis.
© The Author(s) 2020. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Entities:  

Keywords:  zzm321990 Trypanosoma cruzizzm321990 ; Chagas disease clinical forms; blood culture; neglected tropical disease

Mesh:

Year:  2021        PMID: 33150435     DOI: 10.1093/trstmh/traa121

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  2 in total

1.  Perspectives for a new drug candidate for Chagas disease therapy.

Authors:  Maria de Nazaré Correia Soeiro
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-03-14       Impact factor: 2.743

2.  Letters to the Editor: Indeterminate form of Chagas Disease: some immunological insights.

Authors:  Alejandro Marcel Hasslocher-Moreno; Sergio Salles Xavier; Roberto Magalhães Saraiva; Andréa Silvestre de Sousa
Journal:  Rev Soc Bras Med Trop       Date:  2022-04-08       Impact factor: 2.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.